High-dose therapy in patients with Hodgkin’s disease: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells

✍ Scribed by Blystad, A K; Holte, H; Kvaløy, S; Smeland, E; Delabie, J; Kvalheim, G

• Book ID: 110013253
• Publisher: Nature Publishing Group
• Year: 2001
• Tongue: English
• Weight: 144 KB
• Volume: 28
• Category: Article
• ISSN: 0007-1188
• DOI: 10.1038/sj.bmt.1703244